The U.S.-China Program for Biomedical Collaborative Research was established in December 2010 by the U.S. National Institutes of Health and the National Natural Science Foundation of China to foster and expand biomedical research of benefit to both countries.
The program is accepting applications to support collaborative basic, translational, and applied research in the areas of allergy, immunology, and infectious diseases, including HIV/AIDS and its co-morbidities and co-infections, cancer, mental health, Parkinson’s disease, and stroke. Letters of intent are due on August 18, 2012, and applications are due on September 18, 2012.
For more information about the program, see the funding opportunity announcement number RFA-AI-12-021 and frequently asked questions.
RFA-AI-12-021: U.S.-China Program for Biomedical Collaborative Research (R01)
Peer Review at NIAID, Questions and Answers -- NIAID Research Funding
Questions and AnswersTable of Contents
- What award types are peer reviewed at NIAID?
- Does NIAID review many investigator-initiated applications?
- Is NIAID peer review similar to CSR peer review?
- Is scientific review group membership confidential?
- Where do I find rosters for NIAID's chartered review committees?
- I am responding to an RFA—where do I find rosters for NIAID's ad hoc review committees?
- If I respond to an NIAID program announcement, can I request a scientific review group?
- How does NIH handle conflict of interest?
- When should I contact reviewers?
- If I'm sending a paper application, how do I know it was assigned to the correct initiative?
- Will NIAID review late applications?
- Do NIAID scientific review officers check my application to make sure it's complete?
- May I send supplementary, missing, or corrected materials after a receipt date?
- What if I can't find the answer to my question in the opportunity announcement or on this page?
- Where can I find more questions and answers about applying and peer review?
- What if my question wasn't answered here, or I'd like to suggest a question?
Questions for Individual OpportunitiesRFA-AI-12-021, U.S.-China Program for Biomedical Collaborative Research (R01)
- What is the purpose of the U.S.-China Program for Biomedical Research Cooperation?
- What is NSFC?
- What are NSFC's eligibility requirements for Chinese collaborators?
- What are NIH’s eligibility requirements for U.S. applicants?
- May applicants outside the U.S. apply for funding from NIH?
- May federal institutions apply for funding?
- May NIH intramural investigators apply for funding?
- What research areas does this initiative support?
- May U.S. investigators apply with a pathogen or research area that is not listed in the announcement?
- How do a U.S. investigator and a Chinese collaborator create an application?
- Does the Chinese collaborator’s NSFC application need to be submitted as part of the NIH application?
- Do U.S. investigators need to include their Chinese collaborators' budgets in their applications?
- Do U.S. investigators need to share confidential or proprietary information with their Chinese collaborators?
- Can NIH staff send confidential or proprietary application information to a Chinese collaborator on behalf of an applicant?
- What is the maximum budget that U.S. applicants can request?
- How much funding can Chinese collaborators request from NSFC?
- Can NIH funds awarded under this program support expenses incurred in China but not included in the Chinese collaborator's project expenses?
- How do U.S. institutions pay for facilities and adminstrative costs for Chinese collaborators?
- Can NIH help U.S. applicants obtain approval from the Chinese government to export biospecimens out of China?
- Are electronic signatures acceptable in the letter of support or other submitted documents?
- Are references included in the 12-page limit for the research strategy?
- Are preliminary data required for this opportunity?
- What are the data sharing requirements?
- Will applicants receive feedback from NIH?
- How will NIH review applications?
- How will NSFC review applications?
- Will reviewers consider the Chinese collaborator’s scientific background when evaluating a U.S. investigator's application?
- Should a U.S. applicant include the Chinese collaborator’s biosketch?
- Must U.S. applicants show evidence of collaboration history with their Chinese collaborators?
- Does a U.S. applicant have to hold an active NIH grant?
- May a U.S. applicant submit more than one application on different projects, each with a different Chinese collaborator?
- Does the research have to be conducted in both the U.S. and China?
- Whom should I contact if I have a question regarding this announcement?
GeneralRead the questions and answers below or see the Table of Contents above.
- Applications in response to some program announcements, including most program announcements that identify location of peer review (PAR) and program announcements with set-aside funds (PAS).
- All applications responding to requests for applications.
- All applications for cooperative agreements and research center grants.
- Certain investigator-initiated applications, including program projects, training grants, career development awards, and clinical trials.
- Contract proposals received in response to solicitations.
Essentially NIAID and CSR conduct the same review with very minor differences.
To learn about peer review of initiatives, read Where are PAs and RFAs reviewed? and other entries in our RFAs, PAs, and Solicitations questions and answers. Also see the following SOPs:
Councils and Committees:
- Acquired Immunodeficiency Syndrome Research Review Committee
- Microbiology and Infectious Diseases Research Committee
- Allergy, Immunology, and Transplantation Research Committee
Though you can see the roster, you cannot request assignment (as you can with a CSR review committee) since there's only one group.
After the peer review meeting, you will get a roster with your summary statement. It will not tell you which panel members were assigned as primary and secondary reviewers (plus at least one additional reader), which is confidential information.
Special Emphasis Panels page. We usually post the roster approximately one month before a review meeting.
Check the site close to the meeting date stated in the RFA. If you still can't find the roster, contact the scientific review officer listed in the RFA notice. Also see Where do I find rosters for NIAID's chartered review committees? above.
If CSR is to review your application, you can and should request a study section. If you don't, NIH will assign your application for you. For more on that, plus links to advice, go to Requesting an Institute and Study Section in the Strategy for NIH Funding.
Members of peer review committees must leave the room during discussions of applications or contract proposals in which they or close associates have an interest that could bias their evaluations.
For details, see the Conflict of Interest in Peer Review SOP and Basic Layout of a Peer Review Meeting in the Strategy for NIH Funding.
When should I contact reviewers? in the Peer Review of Applications questions and answers.
Commons along with other assignment information. Check periodically and the information will appear.
Late Applications SOP.
SROs Assess Completeness, Assign Reviewers in the Strategy for NIH Funding.
Application, Peer Review, and NIAID Program Project (P01) Applications questions and answers.
mailto:firstname.lastname@example.org?Subject=Q and A feedback&Body=(Please include the Q and A title or a link in your message.) with the title of this page or its URL and your question or comment. We answer questions by email and post them here. Thanks for helping us clarify and expand our knowledge base.
NIH published this RFA in an April 4, 2012, Guide notice.
U.S. and Chinese investigators work together to identify projects that address the research objectives and funding requirements described in the April 4, 2012, Guide notice.
Chinese or English.
Internet-based Science Information System.
Potential collaborators and scientists in Special Administrative Regions of China (e.g., Hong Kong) should contact NSFC to discuss their eligibility requirements.
For more details on eligibility requirements for Chinese collaborators, go to the NSFC Funding Opportunity Announcement (in Chinese).
April 4, 2012, Guide notice and note the following:
- Chinese collaborators must be current or former NSFC grantees.
- To be considered for funding, both the U.S. and Chinese applications must be determined to be eligible and responsive by their respective organizations.
Applications must list at least one investigator from a U.S. institution as the Program Director/Principal Investigator, and name the Chinese investigator as a collaborating partner.
Contact your agency to find out if it is eligible.
For more information, contact:
- For NCI/CCR PIs (in scientific areas other than HIV/AIDS and its comorbidities), contact Janelle Cortner or David Goldstein.
- For NCI/DCEG PIs (in scientific areas other than HIV/AIDS and its comorbidities), contact Marianne Henderson.
- For NIAID PIs (in scientific areas other than HIV/AIDS and its comorbidities), contact Mark Pineda and Gayle Bernabe.
- For NIMH PIs (in scientific areas other than HIV/AIDS and its comorbidities), contact the NIMH Referral Office at email@example.com.
- For NIH PIs working in the area of HIV/AIDS and its comorbidities, contact Bob Eisinger and Joan Romaine.
- For NIH PIs working in the areas of Parkinson’s Disease or stroke (in scientific areas other than HIV/AIDS and its comorbidities), contact Peggy Rollins.
- Clinical trials (because of NSFC’s policy restrictions).
- Research involving select agents.
- Cancer studies that do not have an infectious agent or disease component.
May U.S. investigators apply with a pathogen or research area that is not listed in the announcement?Possibly, depending on the research focus (as indicated for each participating NIH institute) and its relevance to the intent of this initiative.
Before submitting their applications, U.S. investigators should discuss research plans with a Scientific/Research Contact listed under Agency Contacts in the April 4, 2012, Guide notice.
Note, however, that certain restrictions to permissible scientific activities are defined in the announcement.
- U.S. investigator submits his or her application to NIH and shares a copy with the Chinese collaborator.
- Chinese collaborator submits the same application to NSFC with additional information requested in the NSFC Funding Opportunity Announcement (in Chinese).
Does the Chinese collaborator’s NSFC application need to be submitted as part of the NIH application?No.
Do U.S. investigators need to share confidential or proprietary information with their Chinese collaborators?Only if they include this information in their applications. PIs concerned about confidentiality or proprietary information should take the sharing requirement into account when deciding what information to include.
Can NIH staff send confidential or proprietary application information to a Chinese collaborator on behalf of an applicant?No. Only applicants can send this information to their collaborators.
NSFC Funding Opportunity Announcement (in Chinese).
Can NIH funds awarded under this program support expenses incurred in China but not included in the Chinese collaborator's project expenses?Yes. U.S. applicants can spend funds in China under this announcement but should justify in their applications why such an expense is needed to complete their research projects. Further, a U.S. investigator's budget should not overlap with that of his or her Chinese collaborator.
Before submitting an application, applicants should discuss budgets that propose to spend funds in China with a Scientific/Research Contact listed under Agency Contacts in the April 4, 2012, Guide notice.
Chinese collaborators receive support directly from NSFC.
For more information on calculating facilities and administrative costs on an NIH grant, contact your institution's business office and read Where do I find guidance on calculating facilities and administrative costs? in our Managing a Grant questions and answers.
Can NIH help U.S. applicants obtain approval from the Chinese government to export biospecimens out of China?No. U.S. applicants should work closely with their Chinese collaborating investigators, who are responsible for obtaining the necessary approvals.
If the proposed research requires exporting biospecimens from China, U.S. applicants must include the following information in their applications:
- Type of biospecimens to be exported.
- Evidence that the applicant has already applied for the required Chinese government approval to export these materials.
- Indication of whether the work can be completed if the Chinese government does not grant this approval.
NIH Data Sharing Policy and Implementation Guidance.
For applications proposing research on Parkinson’s disease (PD) on U.S. patients:
- All genetic studies must share data using dbGaP.
- All laboratory-based PD studies on human specimen and clinical PD biomarker projects, including imaging studies, must comply with NINDS Parkinson's Disease Biomarkers Program (PDPB) Strategy requirements.
- U.S. grantees may have to deposit some human biological samples collected under this program into the NINDS Human Genetics DNA and Cell Line Repository as directed by NINDS. They must also share clinical, imaging and biological data using the PDBP Data Management Resource and include a plan for sharing data using that system.
- When planning an application, U.S. investigators should follow the approval process in China for international sharing of the biological samples and genetic data.
April 4, 2012, Guide notice. Applicants can see their review assignments in the eRA Commons after they apply.
NIH makes funding decisions based on the research priorities of the U.S.-China program.
Will reviewers consider the Chinese collaborator’s scientific background when evaluating a U.S. investigator's application?Yes. Reviewers will evaluate all investigators for appropriate scientific background to conduct the proposed research.
May a U.S. applicant submit more than one application on different projects, each with a different Chinese collaborator?Yes, as long as the applications are scientifically distinct. Note that NIH will not accept any application that is essentially the same as one already reviewed or pending initial peer review.
Agency Contacts in the April 4, 2012, Guide notice.